SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001193125-15-095588
Filing Date
2015-03-17
Accepted
2015-03-17 17:25:07
Documents
3
Group Members
SUN MERGER SUB, INC.VALEANT PHARMACEUTICALS INTERNATIONAL

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A d892433dsctota.htm SC TO-T/A 48317
2 EX.99.A.1.VII d892433dex99a1vii.htm EX-99.A.1.VII 94361
3 GRAPHIC g892433g84p52.jpg GRAPHIC 38087
  Complete submission text file 0001193125-15-095588.txt   197273
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filed by) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: SC TO-T/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 8510 COLONNADE CENTER DRIVE RALEIGH NC 27615
Business Address 8510 COLONNADE CENTER DRIVE RALEIGH NC 27615 (919) 862-1000
SALIX PHARMACEUTICALS LTD (Subject) CIK: 0001009356 (see all company filings)

IRS No.: 943267443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-53269 | Film No.: 15707937
SIC: 2834 Pharmaceutical Preparations